Pyridostigmine Bromide (ALVOGEN INC.)
Welcome to the PulseAid listing for the Pyridostigmine Bromide drug offered from ALVOGEN INC.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ALVOGEN INC. |
NON-PROPRIETARY NAME: | Pyridostigmine Bromide |
SUBSTANCE NAME: | PYRIDOSTIGMINE BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-06-29 |
END MARKETING DATE: | 0000-00-00 |
Pyridostigmine Bromide HUMAN PRESCRIPTION DRUG Details:
Item Description | Pyridostigmine Bromide from ALVOGEN INC. |
LABELER NAME: | ALVOGEN INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 180(mg/1) |
START MARKETING DATE: | 2015-06-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47781-335_809df75c-e42a-2fd6-182c-03f8defe21dc |
PRODUCT NDC: | 47781-335 |
APPLICATION NUMBER: | ANDA204737 |
Other PYRIDOSTIGMINE BROMIDE Pharmaceutical Manufacturers / Labelers: